- Section 1 Patients and their treatment
- Section 2 Background to medicine
- 2.1 Science in medicine: When, how, and what
- 2.2 Evolution: Medicine’s most basic science
- 2.3 The Global Burden of Disease: Measuring the health of populations
- 2.4 Large-scale randomized evidence: Trials and meta-analyses of trials
- 2.5 Bioinformatics
- 2.6 Principles of clinical pharmacology and drug therapy
- 2.7 Biological therapies for immune, inflammatory, and allergic diseases
- 2.8 Traditional medicine exemplified by traditional Chinese medicine
- 2.9 Engaging patients in therapeutic development
- 2.10 Medicine quality, physicians, and patients
- 2.11 Preventive medicine
- 2.12 Medical screening
- 2.13 Health promotion
- 2.14 Deprivation and health
- 2.15 How much should rich countries’ governments spend on healthcare?
- 2.16 Financing healthcare in low-income developing countries: A challenge for equity in health
- 2.17 Research in the developed world <i>(a view from the Wellcome Trust</i>)
- 2.18 Fostering medical and health research in resource-constrained countries
- 2.19 Regulation versus innovation in medicine
- 2.20 Human disasters
- 2.21 Humanitarian medicine
- 2.22 Complementary and alternative medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine
(p. 124) Medicine quality, physicians, and patients
- Chapter:
- (p. 124) Medicine quality, physicians, and patients
- Author(s):
Paul N. Newton
- DOI:
- 10.1093/med/9780198746690.003.0016
Poor-quality medicines negate the enormous advantages of modern pharmaceuticals and lead to avoidable morbidity and mortality; loss of confidence in medicines and healthcare systems; economic losses for patients, their families, governments, and the pharmaceutical industry; and—for anti-infectives—engender pathogen drug resistance.
There are many examples of both falsified (due to fraudulent production) and substandard (due to in-factory negligence) medicines, vaccines, diagnostic tests, and devices. New portable diagnostic devices offer hope that they could empower medicine inspectors and pharmacists to obtain objective evidence for selection of suspicious samples for formal analysis. Much greater international effort is needed for the reporting of poor-quality medicines so that detection can be acted upon and patients protected.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 Patients and their treatment
- Section 2 Background to medicine
- 2.1 Science in medicine: When, how, and what
- 2.2 Evolution: Medicine’s most basic science
- 2.3 The Global Burden of Disease: Measuring the health of populations
- 2.4 Large-scale randomized evidence: Trials and meta-analyses of trials
- 2.5 Bioinformatics
- 2.6 Principles of clinical pharmacology and drug therapy
- 2.7 Biological therapies for immune, inflammatory, and allergic diseases
- 2.8 Traditional medicine exemplified by traditional Chinese medicine
- 2.9 Engaging patients in therapeutic development
- 2.10 Medicine quality, physicians, and patients
- 2.11 Preventive medicine
- 2.12 Medical screening
- 2.13 Health promotion
- 2.14 Deprivation and health
- 2.15 How much should rich countries’ governments spend on healthcare?
- 2.16 Financing healthcare in low-income developing countries: A challenge for equity in health
- 2.17 Research in the developed world <i>(a view from the Wellcome Trust</i>)
- 2.18 Fostering medical and health research in resource-constrained countries
- 2.19 Regulation versus innovation in medicine
- 2.20 Human disasters
- 2.21 Humanitarian medicine
- 2.22 Complementary and alternative medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine